Posaconazole-associated severe hyperbilirubinemia in acute myeloid leukemia following chemotherapy: A case report

doi:10.12998/wjcc.v6.i16.1206

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 16

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6052)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series.

Item

Count

PDF

298

WORD

213

HTML

3524

Figures (1-1)

151

Sum=4186

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

783

Download

1083

Sum=1866

Dec 26, 2018 (publication date) through Apr 26, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Dec 26, 2018; 6(16): 1206-1209
Published online Dec 26, 2018. doi: 10.12998/wjcc.v6.i16.1206

Open in New Tab Full Size Figure Download Figure

Figure 1 Relationship between total serum bilirubin and medication process.

Citation: Song ZW, Pan YC, Huang ZC, Liu WX, Zhao RS, Jing HM, Dong F. Posaconazole-associated severe hyperbilirubinemia in acute myeloid leukemia following chemotherapy: A case report. World J Clin Cases 2018; 6(16): 1206-1209
URL: https://www.wjgnet.com/2307-8960/full/v6/i16/1206.htm
DOI: https://dx.doi.org/10.12998/wjcc.v6.i16.1206